Llwytho...
PCSK9 targets important for lipid metabolism
Ischemic heart disease is the main cause of death worldwide and it is accelerated by increased low-density lipoprotein (LDL) cholesterol (LDL-C) and/or lipoprotein (a) (Lp(a)) concentrations. Proprotein convertase subtilisin/kexin type 9 (PCSK9) alters both LDL-C and in part Lp(a) concentrations thr...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Clin Res Cardiol Suppl |
---|---|
Prif Awduron: | , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Springer Berlin Heidelberg
2017
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352789/ https://ncbi.nlm.nih.gov/pubmed/28176216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11789-017-0085-0 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|